Skip to main content
  • Main menu
  • User menu
  • Search
  • English ▼
    • English
    • Afrikaans
    • Albanian
    • Amharic
    • Arabic
    • Armenian
    • Azerbaijani
    • Basque
    • Belarusian
    • Bengali
    • Bosnian
    • Bulgarian
    • Catalan
    • Cebuano
    • Chichewa
    • Chinese (Simplified)
    • Chinese (Traditional)
    • Corsican
    • Croatian
    • Czech
    • Danish
    • Dutch
    • Esperanto
    • Estonian
    • Filipino
    • Finnish
    • French
    • Frisian
    • Galician
    • Georgian
    • German
    • Greek
    • Gujarati
    • Haitian Creole
    • Hausa
    • Hawaiian
    • Hebrew
    • Hindi
    • Hmong
    • Hungarian
    • Icelandic
    • Igbo
    • Indonesian
    • Irish
    • Italian
    • Japanese
    • Javanese
    • Kannada
    • Kazakh
    • Khmer
    • Korean
    • Kurdish (Kurmanji)
    • Kyrgyz
    • Lao
    • Latin
    • Latvian
    • Lithuanian
    • Luxembourgish
    • Macedonian
    • Malagasy
    • Malay
    • Malayalam
    • Maltese
    • Maori
    • Marathi
    • Mongolian
    • Myanmar (Burmese)
    • Nepali
    • Norwegian
    • Pashto
    • Persian
    • Polish
    • Portuguese
    • Punjabi
    • Romanian
    • Russian
    • Samoan
    • Scottish Gaelic
    • Serbian
    • Sesotho
    • Shona
    • Sindhi
    • Sinhala
    • Slovak
    • Slovenian
    • Somali
    • Spanish
    • Sudanese
    • Swahili
    • Swedish
    • Tajik
    • Tamil
    • Telugu
    • Thai
    • Turkish
    • Ukrainian
    • Urdu
    • Uzbek
    • Vietnamese
    • Welsh
    • Xhosa
    • Yiddish
    • Yoruba
    • Zulu

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

English ▼
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scottish Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sudanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleBrief Communication

68Ga-Pentixafor PET/CT Demonstrating In Vivo CXCR4 Receptor Overexpression in Rare Lung Malignancies: Correlation with Histologic and Histochemical Findings

Ankit Watts, Baljinder Singh, Harmandeep Singh, Harneet Kaur, Amanjit Bal, Mehak Vohra, Sunil K. Arora and D. Behera
Journal of Nuclear Medicine Technology September 2022, 50 (3) 278-281; DOI: https://doi.org/10.2967/jnmt.122.264141
Ankit Watts
1Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Baljinder Singh
1Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harmandeep Singh
1Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harneet Kaur
1Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanjit Bal
2Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mehak Vohra
3Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sunil K. Arora
3Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. Behera
4Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    A 73-y-old woman (patient 2) with primary lung hemangioendothelioma. (A, B, and D) 68Ga-pentixafor PET/CT maximum-intensity projection (A) and cross-sectional PET/CT image (B) showing increased uptake (SUVmax, 13.0), with corresponding CT image (D). (C, E, and F) FACS analysis using CD184-PE showing stained CXCR4-positive tumor cells in scatterplots (C), photomicrograph with histopathologic disease evidence showing epithelioid tumor cells (hematoxylin and eosin, ×40) (E) and immunohistochemistry staining with CD31 showing diffuse membranous positivity (F).

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    A 70-y-old woman (patient 4) with secondary lung cancer disease. (A) 68Ga-pentixafor PET/CT maximum-intensity projection showing increased uptake in lung and in multiple sarcomatoid lesions. (B, D, and F) Cross-sectional PET/CT image showing increased (SUVmax, 9.5) uptake in metastatic lung lesion (B), in posterior subcutaneous lesions and left lateral aspect of scalp (SUVmax, 4.6) (D), and in lytic expansile lesion with soft-tissue component involving lateral aspect of fifth rib (SUVmax, 5.4) (F). (C) FACS analysis using CD184-PE showing stained CXCR4-positive tumor cells in scatterplots. (E) Photomicrograph with histopathologic disease evidence (hematoxylin and eosin, ×40).

Tables

  • Figures
    • View popup
    TABLE 1.

    Findings in 6 Patients with Rare Lung Tumors and Metastatic Lung Disease

    FACS analysis
    Patient no.Age (y)SexHistopathology68Ga-pentixafor PET SUVmaxMFICXCR-positive tumor cells (%)
    173FSarcomatoid carcinoma (primary tumor)6.34110.502.70
    233FHemangioendothelioma (primary tumor)13.0682.073.60
    368MHemangiopericytoma (primary tumor)3.027.902.50
    470FLung metastasis (primary sarcoma)9.5191.2045.2
    540MLung metastasis (primary renal cell carcinoma)6.062.047.0
    658MLung metastasis (unknown primary)7.5216.659.2
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 50 (3)
Journal of Nuclear Medicine Technology
Vol. 50, Issue 3
September 1, 2022
  • Table of Contents
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Email Article
Citation Tools
Share
68Ga-Pentixafor PET/CT Demonstrating In Vivo CXCR4 Receptor Overexpression in Rare Lung Malignancies: Correlation with Histologic and Histochemical Findings
Ankit Watts, Baljinder Singh, Harmandeep Singh, Harneet Kaur, Amanjit Bal, Mehak Vohra, Sunil K. Arora, D. Behera
Journal of Nuclear Medicine Technology Sep 2022, 50 (3) 278-281; DOI: 10.2967/jnmt.122.264141
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Patient Motion During Cardiac PET Imaging
  • Logistics of Adopting 177Lu-Vipivotide Tetraxetan Therapy in a Community-Based Hospital Setting
  • Fitness for Purpose of Text-to-Image Generative Artificial Intelligence Image Creation in Medical Imaging
Show more Brief Communication

Similar Articles

Keywords

  • [68Ga]pentixafor
  • PET/CT imaging
  • CXCR4 receptors
  • lung cancer
  • rare variants
  • metastasis
SNMMI

© 2025 SNMMI

Powered by HighWire
Alerts for this Article
Sign In to Email Alerts with your Email Address
Email this Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
68Ga-Pentixafor PET/CT Demonstrating In Vivo CXCR4 Receptor Overexpression in Rare Lung Malignancies: Correlation with Histologic and Histochemical Findings
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
68Ga-Pentixafor PET/CT Demonstrating In Vivo CXCR4 Receptor Overexpression in Rare Lung Malignancies: Correlation with Histologic and Histochemical Findings
Ankit Watts, Baljinder Singh, Harmandeep Singh, Harneet Kaur, Amanjit Bal, Mehak Vohra, Sunil K. Arora, D. Behera
Journal of Nuclear Medicine Technology Sep 2022, 50 (3) 278-281; DOI: 10.2967/jnmt.122.264141

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

We use cookies on this site to enhance your user experience

By clicking any link on this page you are giving your consent for us to set cookies.